UBS’s Chimerix, Inc. CMRX Stock Holding History

UBS’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$6K	Hold	200	–	–	﹤0.01%	9319
2014 Q2	$4K	Hold	200	–	–	﹤0.01%	9705
2014 Q1	$5K	Buy	+200	New	+$4.04K	﹤0.01%	9564

Other funds holding CMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS's CMRX Position: Q3 2014 in Review

UBS held its Chimerix, Inc. (CMRX) position steady in Q3 2014 at 200 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9319.

UBS first reported a position in CMRX in Q1 2014 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold CMRX as of Q3 2014.

UBS held 200 shares of Chimerix, Inc. worth $6K as of Q3 2014.
UBS left its Chimerix, Inc. share count unchanged in Q3 2014.
Chimerix, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9319 holding.
UBS first reported a position in Chimerix, Inc. in Q1 2014 and has held it in 3 quarters since.
103 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.